us en false false Default
Skip directly to Accessibility Notice
PPH VanEck Pharmaceutical ETF Please read important disclosure Close important disclosure false

PPH
VanEck Pharmaceutical ETF

PPH
VanEck Pharmaceutical ETF

  • NAV
    $101.26

    as of March 24, 2026
  • YTD RETURNS
    -1.80%

    as of March 24, 2026
  • Total Net Assets
    $1.27B

    as of March 24, 2026
  • Total Expense Ratio
    0.36%
  • Inception Date
    12/20/2011

About PPH

VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Buy Now
Let's Connect
Subscribe

Overview

Why PPH

  • Highly Liquid Companies: Tracks the largest most liquid pharmaceutical companies
  • Industry Leaders: Favors established industry leaders with meaningful scale
  • Global Scope: Provides exposure to U.S. and international equities for global industry representation  

Performance

Performance History:

Average Annual Total Returns* (%)

View All ETFs View All Indices
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 4.61 9.25 8.32 21.70 16.20 12.72 8.95 10.50
PPH (Market Price) 4.58 9.29 8.27 21.72 16.20 12.68 8.95 10.57
MVPPHTR (Index) 4.59 9.23 8.27 21.38 15.75 12.34 8.72 10.31
Performance Differential (NAV - Index) 0.02 0.02 0.05 0.32 0.45 0.38 0.23 0.19
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 0.86 14.97 21.92 21.92 12.11 11.34 6.74 10.00
PPH (Share Price) 0.95 15.00 22.03 22.03 12.14 11.34 6.73 10.08
MVPPHTR (Index) 0.89 15.01 21.58 21.58 11.64 10.88 6.49 9.81
Performance Differential (NAV - Index) -0.03 -0.04 0.34 0.34 0.47 0.46 0.25 0.19

*Returns less than one year are not annualized.

The performance data quoted represents past performance. Past performance is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Please call 800.826.2333 or visit vaneck.com for performance current to the most recent month ended.

Prices as of 03/24/2026

NAV/
Market
Price 		Volume
30-Day Avg./
Last Trading Day 		Daily Change
NAV/
Last Price 		YTD Change NAV/
Last Price 		Premium/
Discount 		30-Day
Median
Bid Ask
Spread 		NAV
Chart
PPH $101.26
$101.25 		368,617
109,777 		$0.33 / +0.32%
$0.32 / +0.32% 		-1.80%
-1.86% 		$-0.01
-0.01% 		0.04%

Fees

Holdings

Daily Holdings (%) as of 03/24/2026

Download XLS Get holdings
Total Holdings: 26
Ticker
 Holding Name % of Net
Assets
Identifier (FIGI)
Shares
 Asset Class Market Value
(US$) 		Notional Value
LLY
 Eli Lilly & Co 18.90
BBG000BNBDC2
265,700
 Stock 239,932,414 --
NVS
 Novartis Ag 10.78
BBG000LYF3S8
920,713
 Stock 136,827,159 --
MRK
 Merck & Co Inc 9.64
BBG000BPD168
1,051,642
 Stock 122,379,580 --
PFE
 Pfizer Inc 5.17
BBG000BR2B91
2,432,768
 Stock 65,587,425 --
NVO
 Novo Nordisk A/S 4.97
BBG000BQBKR3
1,710,392
 Stock 63,096,361 --
SNY
 Sanofi Sa/France 4.56
BBG000BBD5N1
1,282,513
 Stock 57,892,637 --
GSK
 Gsk Plc 4.52
BBG000BLB481
1,083,828
 Stock 57,388,693 --
BMY
 Bristol-Myers Squibb Co 4.50
BBG000DQLV23
996,551
 Stock 57,192,062 --
MCK
 Mckesson Corp 4.44
BBG000DYGNW7
63,976
 Stock 56,422,993 --
JNJ
 Johnson & Johnson 4.30
BBG000BMHYD1
231,917
 Stock 54,563,113 --
AZN
 Astrazeneca Plc 4.27
BBG000D3MHB4
291,519
 Stock 54,158,400 --
COR
 Cencora Inc 4.01
BBG000MDCQC2
155,441
 Stock 50,871,176 --
ABBV
 Abbvie Inc 4.00
BBG0025Y4RY4
247,513
 Stock 50,789,668 --
ZTS
 Zoetis Inc 3.51
BBG0039320N9
384,152
 Stock 44,534,741 --
HLN
 Haleon Plc 3.21
BBG018GZNCH6
4,201,779
 Stock 40,757,256 --
TAK
 Takeda Pharmaceutical Co Ltd 3.16
BBG000LF8708
2,220,949
 Stock 40,065,920 --
TEVA
 Teva Pharmaceutical Industries Ltd 2.82
BBG000C0CD58
1,227,891
 Stock 35,780,744 --
VTRS
 Viatris Inc 0.91
BBG00Y4RQNH4
868,916
 Stock 11,608,718 --
JAZZ
 Jazz Pharmaceuticals Plc 0.81
BBG000G9CGL0
55,339
 Stock 10,238,268 --
AXSM
 Axsome Therapeutics Inc 0.50
BBG00B6G7GL7
39,739
 Stock 6,308,566 --
ELAN
 Elanco Animal Health Inc 0.38
BBG00LJYS1P8
193,115
 Stock 4,808,564 --
CORT
 Corcept Therapeutics Inc 0.19
BBG000BKJG33
72,012
 Stock 2,435,446 --
OGN
 Organon & Co 0.10
BBG00ZQRGW24
213,786
 Stock 1,306,232 --
BHC
 Bausch Health Cos Inc 0.10
BBG000DLFM21
251,090
 Stock 1,252,939 --
PRGO
 Perrigo Co Plc 0.07
BBG000CNFQW6
85,547
 Stock 824,673 --
-USD CASH-
 -0.00
--
-5,381
 Cash Bal -5,381 --
--
Other/Cash 0.20
--
0
 Cash 2,580,197 --
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Portfolio

Sector Weightings (%) as at 02/28/2026

  • Sector

    % of Net Assets

  • Health Care

    99.96

  • Other/Cash

    0.04

Country Weightings (%) as at 02/28/2026

  • Country

    % of Net Assets

  • United States

    62.18

  • United Kingdom

    12.48

  • Switzerland

    11.37

  • Denmark

    4.40

  • France

    4.04

  • Japan

    2.88

  • Israel

    2.62

  • Other/Cash

    0.04

Distributions

Yields  as of  03/24/2026

Distribution Frequency

Quarterly

30-Day SEC Yield

2.01%

Distribution Yield

1.23%

12 Month Yield

1.81%

Yield information reflects temporary waivers of expenses and/or fees. Yields would have been reduced had these fees/expenses been included. In the absence of temporary expense waivers or reimbursements, the 30-Day SEC Yield for VanEck Pharmaceutical ETF would have been 2.01% on 03/24/26. Distributions may vary from time to time.

Team

Literature

PPH